Building Better Data and Analytics in the Evolving Construction Industry

From drones and bleeding-edge technology to the end-to-end processes that drive efficiency, modern construction is undergoing a renaissance. Host Shaun MacIntosh talks with the top leaders in construction and provides unmatched insights into the industry that quite literally built the world around us.

 

The construction industry is adopting technology to work smarter, not harder. On Track.Map.Measure. delivers insights on how the field is evolving. Host Shaun MacIntosh took listeners on a deep dive into software with guest Tom Wiley, Senior Solutions Engineer at B2W Software. B2W Software offers a unified construction software that connects people, workflows, and data.

Wiley has been with the company for over 15 years and now focuses on solutions engineering. “It’s a fun and unique role where I talk to customers at the discovery phase to learn their problems and come up with creative and practical solutions to solve them,” he shared.

The importance of data in construction, just like in other industries, is rising. Capturing it and analyzing it can lead to better decision-making, greater efficiencies, and higher profitability. So, what’s the catalyst for construction companies shopping for software?

“It starts with some kind of problem, an impediment to growth or maximizing profitability. Often problems uncover other problems, too. Companies realize they can’t keep doing things the same way to grow and be competitive,” Wiley answered.

Deploying software can lead to benefits. “One story is a company that couldn’t bid fast enough with one full-time estimator and one part-time. After the implementation, they still had one estimator but doubled their bidding amount,” Wiley said.

The embrace of data to drive business is likely the next-generation of construction companies. “Tracking and making use of data can give you daily, weekly, or monthly basis on that cost. You’re fixing problems as they’re happening. These tools bring real value to those that use them,” Wiley added.

Listen to Previous Episodes of Track.Map.Measure Right Here!

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More